Literature DB >> 10515832

Human herpesvirus 8 cellular immune responses in homosexual men.

H D Strickler1, J J Goedert, F R Bethke, C M Trubey, T R O'Brien, J Palefsky, J E Whitman, D Ablashi, S Zeichner, G M Shearer.   

Abstract

Little is known about cellular immunity to human herpesvirus 8 (HHV-8), the virus associated with Kaposi's sarcoma (KS). T cell proliferative responses to purified HHV-8 were measured in homosexual men, a group with elevated HHV-8 seroprevalence and high risk of KS. None of 20 blood donor controls had T cell responses to HHV-8. Among human immunodeficiency virus (HIV)-negative homosexual men, 8 (42%) of 19 HHV-8 seropositive men responded as did 4 (16%) of 25 HHV-8 seronegative men. Among HIV-positive homosexual men, however, none of 21 HHV-8 seropositives had T cell responses to HHV-8, even though most responded to common recall antigens, and 10 had >/=400 CD4 cells/mm3. The results suggest that HHV-8 T cell proliferative responses are common in HIV-negative homosexual men and that HIV infection may be associated with diminished HHV-8 cellular immunity, possibly before there is substantial depletion of CD4 cells. If correct, this could explain why KS occurs relatively early in HIV infection/AIDS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10515832     DOI: 10.1086/315056

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Reconstitution of immune responses against Kaposi sarcoma-associated herpesvirus.

Authors:  Roberto Flores; James J Goedert
Journal:  AIDS       Date:  2010-09-10       Impact factor: 4.177

Review 2.  HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease.

Authors:  Ryan J Sullivan; Liron Pantanowitz; Corey Casper; Justin Stebbing; Bruce J Dezube
Journal:  Clin Infect Dis       Date:  2008-11-01       Impact factor: 9.079

3.  Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice.

Authors:  Gianna Ballon; Kang Chen; Rocio Perez; Wayne Tam; Ethel Cesarman
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

Review 4.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

5.  Monofunctional and polyfunctional CD8+ T cell responses to human herpesvirus 8 lytic and latency proteins.

Authors:  Lauren Lepone; Giovanna Rappocciolo; Emilee Knowlton; Mariel Jais; Paolo Piazza; Frank J Jenkins; Charles R Rinaldo
Journal:  Clin Vaccine Immunol       Date:  2010-08-18

Review 6.  Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update.

Authors:  Kawalpreet K Aneja; Yan Yuan
Journal:  Front Microbiol       Date:  2017-04-20       Impact factor: 5.640

Review 7.  Microbes as Master Immunomodulators: Immunopathology, Cancer and Personalized Immunotherapies.

Authors:  Joana R Lérias; Georgia Paraschoudi; Eric de Sousa; João Martins; Carolina Condeço; Nuno Figueiredo; Carlos Carvalho; Ernest Dodoo; Mireia Castillo-Martin; Antonio Beltrán; Dário Ligeiro; Martin Rao; Alimuddin Zumla; Markus Maeurer
Journal:  Front Cell Dev Biol       Date:  2020-01-23

8.  Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda.

Authors:  Angela Nalwoga; Romin Roshan; Kyle Moore; Vickie Marshall; Wendell Miley; Nazzarena Labo; Marjorie Nakibuule; Stephen Cose; Rosemary Rochford; Robert Newton; Denise Whitby
Journal:  Nat Commun       Date:  2021-12-16       Impact factor: 14.919

9.  Professional antigen presenting cells in human herpesvirus 8 infection.

Authors:  Emilee R Knowlton; Lauren M Lepone; Jun Li; Giovanna Rappocciolo; Frank J Jenkins; Charles R Rinaldo
Journal:  Front Immunol       Date:  2013-01-21       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.